HomeGeneticsConditionAmyotrophic lateral sclerosis
Back to Condition
Amyotrophic lateral sclerosis
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive disease that causes the death of motor neurons, leading to muscle weakness, atrophy, and eventually the loss of the ability to control movement.

Overview

ALS affects motor neurons, the specialized nerve cells that control muscle movement. As these cells die over time, individuals experience muscle weakness, loss of muscle mass, and an inability to control movement. Most cases are sporadic, occurring in people with no family history of the disorder. A small percentage (5 to 10 percent) is familial, meaning it is inherited.

Symptoms

  • Muscle twitching, cramping, stiffness, or weakness
  • Slurred speech (dysarthria)
  • Difficulty chewing or swallowing (dysphagia)
  • Malnutrition due to swallowing difficulties
  • Progressive loss of muscle strength and ability to walk
  • Respiratory muscle weakness

Some individuals may also develop frontotemporal dementia (FTD), which affects personality, behavior, and communication. A rare form, ALS-parkinsonism-dementia complex (ALS-PDC), includes movement abnormalities such as slow movements (bradykinesia), stiffness, and tremors.

Causes

The cause of sporadic ALS is largely unknown but likely involves a combination of genetic and environmental factors. Familial ALS is caused by mutations in several genes, most notably C9orf72, SOD1, TARDBP, and FUS. These mutations are thought to disrupt the function of motor neurons, potentially through the buildup of protein clumps (aggregates) or by impairing the transmission of nerve impulses to muscles.

Inheritance

While 90 to 95 percent of cases are sporadic, familial ALS can be inherited in several ways:

  • Autosomal dominant: One copy of the altered gene is sufficient to cause the disorder.
  • Autosomal recessive: Both copies of the gene must have mutations to cause the disorder.
  • X-linked: The mutation occurs on the X chromosome; this is very rare.

Frequently Asked Questions

The first clues often include subtle muscle twitching (fasciculations), cramps, or a gradual loss of strength in a hand or foot. You may notice difficulty with fine motor tasks, slurred or slowed speech, trouble chewing or swallowing, and a sense of fatigue that worsens with activity. If any of these symptoms persist for more than a few weeks, schedule an appointment with a neurologist for a focused evaluation.
The need for a feeding tube typically arises when swallowing becomes unsafe or when weight loss reaches 10–15% of baseline. This often occurs 1–3 years after diagnosis but can vary widely. Respiratory support, such as a non‑invasive ventilator, is usually considered when forced vital capacity falls below 50% of predicted or when daytime CO₂ levels rise. Early involvement of a multidisciplinary ALS clinic can help anticipate and plan for these interventions.
Driving is generally safe as long as you have adequate muscle control, vision, and speech. Most patients can drive for the first 1–2 years, but you should stop if you experience significant slurred speech, facial weakness, or difficulty with hand movements. Daily activities can often be maintained with adaptive equipment (e.g., reachers, voice‑activated devices) and occupational therapy. Regular reassessment with your care team will help determine when modifications are needed.
While no treatment stops ALS, medications such as Riluzole and Edaravone can modestly extend survival. Regular physical therapy focused on gentle range‑of‑motion exercises, speech therapy for swallowing and communication, and respiratory exercises (e.g., diaphragmatic breathing) can preserve function. Maintaining a balanced diet, staying hydrated, and avoiding smoking or excessive alcohol also support overall health. Participation in clinical trials may provide access to emerging therapies.===
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab